Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Kalinox 170 bar efficacy during percutaneous liver biopsy of focal hepatic lesions
2006-004203-19Phase 4Completed
- Sponsor
- Air Liquide
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nitrous oxide, sponsored by Air Liquide. Primary endpoint: Maximum pain during liver biopsy. Started Oct 2006; status: completed.
02
Drugs
nitrous oxide
Beyond the preview
Go deeper on 2006-004203-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004203-19.